The RTS,S malaria vaccine: Journey from conception to recommendation
- PMID: 36570405
- PMCID: PMC9773038
- DOI: 10.1016/j.puhip.2022.100283
The RTS,S malaria vaccine: Journey from conception to recommendation
Abstract
The RTS,S malaria vaccine was recently recommended for use among children at risk in malaria endemic regions. Although significant efforts have been made to minimise malaria cases, the results of these innovations have not been totally satisfactory due to specific limitations. However, this revolutionary vaccine has a great tendency to put an end to malaria. Being the first vaccine against malaria, this commentary examines its journey from the idealisation and conception to the recommendation by the World Health Organization. The commentary also examines some of the challenges that might affect the execution of the vaccination programme in sub-Saharan Africa and other malaria endemic regions and suggest recommendations to overcome the possible them.
Keywords: Malaria; RTS,S; Sub-saharan africa; Vaccine.
© 2022 Published by Elsevier Ltd on behalf of The Royal Society for Public Health.
Conflict of interest statement
The author declares no conflict of interest.
References
-
- World Health Organization . 2021. WHO Recommends Groundbreaking Malaria Vaccine for Children at Risk.https://www.who.int/news/item/06-10-2021-who-recommends-groundbreaking-m...
-
- PATH malaria vaccine initiative. RTS,S. https://www.malariavaccine.org/malaria-and-vaccines/rtss; [accessed 02 June 2022].
LinkOut - more resources
Full Text Sources
